Orange Book product · Brand (NDA)
ATONCY
ATOMOXETINE HYDROCHLORIDE
At a glance
Mar 20, 2026
Approved
Brand (NDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Mar 20, 2026
3 mo ago
Today
Pharmaceutical detail
Active ingredient
ATOMOXETINE HYDROCHLORIDE
Strength
EQ 4MG BASE/ML
Dosage form
SOLUTION
Route
ORAL
TE code
Not listed
Application
NDA 220320
Product number
001
Marketing status
RX
Reference listed drug (RLD)
Yes
Reference standard (RS)
Yes
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
- 2002STRATTERABrand (NDA)
NDA 021411 · LILLY
- 2023ATOMOXETINE HYDROCHLORIDEGeneric (ANDA)
ANDA 079017 · ZYDUS PHARMS USA INC
- 2021ATOMOXETINE HYDROCHLORIDEGeneric (ANDA)
ANDA 202682 · HETERO LABS LTD V
- 2021ATOMOXETINE HYDROCHLORIDEGeneric (ANDA)
ANDA 079021 · STRIDES PHARMA
- 2018ATOMOXETINE HYDROCHLORIDEGeneric (ANDA)
ANDA 090609 · DR REDDYS
- 2017ATOMOXETINE HYDROCHLORIDEGeneric (ANDA)
ANDA 078983 · APOTEX
- 2017ATOMOXETINE HYDROCHLORIDEGeneric (ANDA)
ANDA 079016 · AUROBINDO PHARMA
- 2017ATOMOXETINE HYDROCHLORIDEGeneric (ANDA)
ANDA 079019 · GLENMARK PHARMS LTD
- 2017ATOMOXETINE HYDROCHLORIDEGeneric (ANDA)
ANDA 079022 · TEVA PHARMS USA
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

